Search Results

Your search for Gregory Bociek, MD, MSc matches 2 pages

Showing 1 - 2

By VIJAYA RAJ BHATT, MBBS, MS, AND R. GREGORY BOCIEK, MD, MSc / February 25, 2023 - Supplement: Conference Highlights ASH 2022 / 2022 ASH Annual Meeting and Exposition

Highlights From the 2022 ASH Annual Meeting and Exposition

The 2022 American Society of Hematology (ASH) Annual Meeting and Exposition took place in the vibrant city of New Orleans. The meeting brought together tens of thousands of participants from across the world to present and discuss the results of studies that ranged from hypothesis-generating to...

leukemia

By Gregory Bociek, MD, MSc / October 25, 2021

BTK Inhibition in CLL: An Embarrassment of Riches

Chronic lymphocytic leukemia (CLL) is a B-cell lymphoproliferative disorder defined by a specific phenotype and the presence of more than 5,000 clonal B cells in the peripheral blood.1 In the absence of this number of circulating cells, its soft-tissue/bone-marrow counterpart is semantically...

Apr

Today In Oncology

Search Results

Your search for Gregory Bociek, MD, MSc matches 2 pages

Highlights From the 2022 ASH Annual Meeting and Exposition

BTK Inhibition in CLL: An Embarrassment of Riches

Adjuvant Pembrolizumab in Renal Cell Carcinoma: Overall Survival in KEYNOTE-564

Combined ICI and VEGF Inhibitor Trials in Cancer Cardiovascular Eligibility Criteria and Adverse Event Reporting

Risk of T-Cell and Second Primary Malignant Neoplasms After CAR T-Cell Therapy

Lack of Research Focused on Older Adults With Cancer May Be Contributing to Disparities in Care

Breast Cancer Survivors: Relationship Satisfaction and Emotional and Physical Well-Being